(Q44459148)

English

High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study

scientific article published on 6 June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study (English)

1 reference

Europe PubMed Central

3 December 2017

1 reference

based on heuristic

inferred from title

author name string

A Josting

1

1 reference

Europe PubMed Central

3 December 2017

M Sieniawski

2

1 reference

Europe PubMed Central

3 December 2017

J-P Glossmann

3

1 reference

Europe PubMed Central

3 December 2017

O Staak

4

1 reference

Europe PubMed Central

3 December 2017

L Nogova

5

1 reference

Europe PubMed Central

3 December 2017

N Peters

6

1 reference

Europe PubMed Central

3 December 2017

M Mapara

7

1 reference

Europe PubMed Central

3 December 2017

B Dörken

8

1 reference

Europe PubMed Central

3 December 2017

Y Ko

9

1 reference

Europe PubMed Central

3 December 2017

B Metzner

10

1 reference

Europe PubMed Central

3 December 2017

J Kisro

11

1 reference

Europe PubMed Central

3 December 2017

V Diehl

12

1 reference

Europe PubMed Central

3 December 2017

A Engert

13

1 reference

Europe PubMed Central

3 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

6 June 2005

1 reference

Europe PubMed Central

3 December 2017

Annals of Oncology

1 reference

Europe PubMed Central

3 December 2017

16

1 reference

Europe PubMed Central

3 December 2017

1359-1365

1 reference

Europe PubMed Central

3 December 2017

8

1 reference

Europe PubMed Central

3 December 2017

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Autologous bone marrow transplantation in adults with non-Hodgkin's lymphoma: a Southwest Oncology Group study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Bone marrow transplantation for non-Hodgkin's lymphoma: a review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multi

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI248

21 January 2018

Identifiers

10.1093/ANNONC/MDI248

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44459148&oldid=2024764567"